Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-04-19 to 2024-04-29
Current total value of award: $185.18
Description: 8510584515!CEFTAZIDIME FOR INJ